PET developer Naviscan has received the CE Mark for both its high-resolution positron emission mammography (PEM) scanner and PET-guided biopsy accessory.
The approval enables the company to market the system in Europe, where it has set up distribution in 13 countries, Naviscan said. The firm has already received the first two orders for the system in Germany and Switzerland.Naviscan's PEM gets CE Mark
Latest in Nuclear Medicine
Theranostic pair ready for testing in lung cancer
January 8, 2026
Niowave expands supply agreement with AstraZeneca
December 18, 2025
AtomVie signs supply agreement with Ionetix for Ac-225 development
December 18, 2025

















